Corvus Pharmaceuticals, Inc. (CRVS)

Last Closing Price: 5.74 (2025-08-29)

Debt to Equity Ratio (Quarterly)

Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity

Corvus Pharmaceuticals, Inc. (CRVS) Debt to Equity Ratio data is not available.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
--
$-8.00M
--
--
$10.26M
$-10.26M
$2.26M
$-8.00M
$-8.00M
$-8.00M
$-8.00M
$-8.00M
$-8.00M
$-10.26M
$-10.56M
77.77M
77.77M
$-0.10
$-0.10
Balance Sheet Financials
$75.78M
$0.25M
$13.68M
$89.46M
$8.51M
--
$0.73M
$9.23M
$80.23M
$80.23M
$80.23M
74.51M
Cash Flow Statement Financials
$-14.04M
$-16.06M
$36.05M
$8.74M
$14.69M
$5.95M
$2.51M
--
--
Fundamental Metrics & Ratios
8.91
--
--
--
Debt to Equity Ratio
--
--
--
--
--
--
--
$-14.19M
--
--
--
--
--
--
--
-9.97%
-9.97%
-8.94%
-9.97%
$1.08
$-0.18
$-0.18